Enterprise Value
1.727B
Cash
554.5M
Avg Qtr Burn
-18.15M
Short % of Float
14.13%
Insider Ownership
3.16%
Institutional Own.
-
Qtr Updated
03/31/23
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
Phase 2b Data readout | ||
DC-853 Details Inflammatory disease, Autoimmune disease | Phase 1 Data readout |